EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022 - New Market Report
Dyslipidemia is a condition in which one or more blood lipid levels are abnormal. It is an underdiagnosed, undertreated, and highly prevalent disease worldwide. Prevalent cases of dyslipidemia in the nine markets is expected to increase from 443.8 million cases in 2012 to 522.0 million cases in 2022 at the rate of 1.76% per year. Factors that influence prevalence include risk factors, disease management, awareness of disease status, population growth, and changes in diagnosis and treatment guidelines. In 2012, India...
View full press release